Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1964 1
1965 1
1967 1
1968 3
1969 1
1970 1
1971 4
1972 2
1973 3
1974 6
1975 5
1976 9
1977 4
1978 4
1979 4
1980 1
1981 5
1982 1
1983 6
1984 11
1985 11
1986 10
1987 5
1988 1
1989 7
1990 3
1991 3
1992 10
1993 6
1994 10
1995 5
1996 6
1997 6
1998 14
1999 4
2000 4
2001 5
2002 3
2003 5
2004 7
2005 9
2006 9
2007 9
2008 10
2009 13
2010 9
2011 6
2012 4
2013 6
2014 7
2015 9
2016 7
2017 10
2018 15
2019 17
2020 11
2021 19
2022 10
2023 12
2024 21
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

402 results

Results by year

Filters applied: . Clear all
Page 1
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.
Rossi C, Manson G, Marouf A, Cabannes-Hamy A, Nicolas-Virelizier E, Maerevoet M, Alcantara M, Molina L, Ceraulo A, Poirée M, Galtier J, Diop N, Delette C, Segot A, Dubois S, Waultier A, Bernard S, Noël R, Guidez S, Kohn M, Bailly S, Moatti H, Touati M, Renaud L, Kanoun S, Cottereau AS, Kirova Y, Peignaux K, Dourthe ME, Simonin M, Leblanc T, Quéro L, Krzisch D, Duléry R, Grenier A, Gastinne T, Casasnovas O, Gallamini A, André M, Morschhauser F, Deau B, Fornecker LM, Ghesquières H. Rossi C, et al. Among authors: renaud l. Eur J Cancer. 2024 Dec;213:115073. doi: 10.1016/j.ejca.2024.115073. Epub 2024 Oct 22. Eur J Cancer. 2024. PMID: 39509848 Free article. Review.
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines.
Renaud L, Donzel M, Decroocq J, Decazes P, Galtier J, Burroni B, Veresezan EL, Sesboüé C, Dartigues P, Chassagne-Clément C, Martin L, Mauduit C, Kaltenbach S, Penther D, Etancelin P, Sibon D, Bailly S, Martin V, Durot E, Kirova Y, Grenier A, Maerevoet M, Bernard W, Naveau L, Cabannes-Hamy A, Cottereau AS, Jacquet-Francillon N, Noel R, Reichert T, Sarkozy C, Bussot L, Bailly S, Amorim S, Krzisch D, Cornillon J, Legendre H, Chevillon F, Cavalieri D, Sesques P, Minard-Colin V, Haioun C, Morschhauser F, Houot R, Jardin F, Tilly H, Traverse-Glehen A, Camus V. Renaud L, et al. Eur J Cancer. 2025 May 2;220:115369. doi: 10.1016/j.ejca.2025.115369. Epub 2025 Mar 22. Eur J Cancer. 2025. PMID: 40157284 Free article. Review.
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Wilson MR, Eyre TA, Kirkwood AA, Wong Doo N, Soussain C, Choquet S, Martinez-Calle N, Preston G, Ahearne M, Schorb E, Moles-Moreau MP, Ku M, Rusconi C, Khwaja J, Narkhede M, Lewis KL, Calimeri T, Durot E, Renaud L, Øvlisen AK, McIlroy G, Ebsworth TJ, Elliot J, Santarsieri A, Ricard L, Shah N, Liu Q, Zayac AS, Vassallo F, Lebras L, Roulin L, Lombion N, Manos K, Fernandez R, Hamad N, Lopez-Garcia A, O'Mahony D, Gounder P, Forgeard N, Lees C, Agbetiafa K, Strüßmann T, Htut TW, Clavert A, Scott H, Guidetti A, Barlow BR, Tchernonog E, Smith J, Miall F, Fox CP, Cheah CY, El Galaly TC, Ferreri AJM, Cwynarski K, McKay P. Wilson MR, et al. Among authors: renaud l. Blood. 2022 Apr 21;139(16):2499-2511. doi: 10.1182/blood.2021014506. Blood. 2022. PMID: 34995350 Free article.
Pomalidomide for multiple myeloma.
Fouquet G, Bories C, Guidez S, Renaud L, Herbaux C, Javed S, Facon T, Leleu X. Fouquet G, et al. Among authors: renaud l. Expert Rev Hematol. 2014 Dec;7(6):719-31. doi: 10.1586/17474086.2014.966074. Epub 2014 Sep 30. Expert Rev Hematol. 2014. PMID: 25265911 Review.
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.
Frontzek F, Renaud L, Dührsen U, Poeschel V, Bernard S, Chartier L, Ketterer N, Récher C, Fitoussi O, Held G, Casasnovas O, Haioun C, Mounier N, Tilly H, Morschhauser F, Le Gouill S, Karsten IE, Duns G, Steidl C, Scott DW, Klapper W, Rosenwald A, Ott G, Molina T, Lenz G, Ziepert M, Altmann B, Thieblemont C, Schmitz N. Frontzek F, et al. Among authors: renaud l. Leukemia. 2024 Oct;38(10):2225-2234. doi: 10.1038/s41375-024-02371-y. Epub 2024 Aug 16. Leukemia. 2024. PMID: 39152324 Clinical Trial.
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5'RACE.
Camus V, Viennot M, Viailly PJ, Drieux F, Veresezan EL, Bobée V, Rainville V, Bohers E, Sesques P, Haioun C, Durot E, Bayaram M, Rossi C, Martin L, Penther D, Kaltenbach S, Bruneau J, Paillassa J, Tournilhac O, Gower N, Willaume A, Antier C, Renaud L, Lévêque E, Decazes P, Becker S, Tonnelet D, Gaulard P, Tilly H, Molina TJ, Traverse-Glehen A, Donzel M, Ruminy P, Jardin F. Camus V, et al. Among authors: renaud l. Blood Adv. 2025 Jan 14;9(1):101-115. doi: 10.1182/bloodadvances.2024013723. Blood Adv. 2025. PMID: 39293080 Free PMC article.
402 results